In a mouse model on rejection of an allogeneic subcutaneous tumor as created by Hammond-McKribben et al. [22], another mTOR inhibitor, the rapamycin derivate SDZ RAD, was used to prevent rejection of allogeneic tumors. This evidence concerns the gene MTOR and neoplasm.